Thalidomide neuropathy - Too much or too long?

被引：17

作者：

Apfel, SC

Zochodne, DW

机构：

[1] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA

[2] Purdue Pharma LLP, Stamford, CT USA

[3] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada

来源：

NEUROLOGY | 2004年 / 62卷 / 12期

关键词：

D O I：

10.1212/01.WNL.0000131766.90137.DF

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2158 / 2159

页数：2

共 16 条

[1] Thalidomide: An antineoplastic agent
Amato R.J.
[J]. Current Oncology Reports, 2002, 4 (1) : 56 - 62
[2] Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients
Bastuji-Garin, S
Ochonisky, S
Bouche, P
Gherardi, RK
Duguet, C
Djerradine, Z
Poli, F
Revuz, J
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) : 1020 - 1026
[3] Thalidomide neurotoxicity - Prospective study in patients with lupus erythematosus
Briani, C
Zara, G
Rondinone, R
Della Libera, S
Ermani, M
Ruggero, S
Ghirardello, A
Zampieri, S
Doria, A
[J]. NEUROLOGY, 2004, 62 (12) : 2288 - 2290
[4] Thalidomide sensory neurotoxicity - A clinical and neurophysiologic study
Cavaletti, G
Beronio, A
Reni, L
Ghiglione, E
Schenone, A
Briani, C
Zara, G
Cocito, D
Isoardo, G
Ciaramitaro, P
Plasmati, R
Pastorelli, F
Frigo, M
Piatti, M
Carpo, M
[J]. NEUROLOGY, 2004, 62 (12) : 2291 - 2293
[5] Thalidomide-induced neuropathy
Chaudhry, V
Cornblath, DR
Corse, A
Freimer, M
Simmons-O'Brien, E
Vogelsang, G
[J]. NEUROLOGY, 2002, 59 (12) : 1872 - 1875
[6] An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer
Drake, MJ
Robson, W
Mehta, P
Schofield, I
Neal, DE
Leung, HY
[J]. BRITISH JOURNAL OF CANCER, 2003, 88 (06) : 822 - 827
[7] Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin
George, A
Marziniak, M
Schäfers, M
Toyka, KV
Sommer, C
[J]. PAIN, 2000, 88 (03) : 267 - 275
[8] Thalidomide-induced neuropathy: a ganglionopathy?
Giannini, F
Volpi, N
Rossi, S
Passero, S
Fimiani, M
Cerase, A
[J]. NEUROLOGY, 2003, 60 (05) : 877 - 878
[9] Low-dose thalidomide treatment for advanced hepatocellular carcinoma
Hsu, C
Chen, CN
Chen, LT
Wu, CY
Yang, PM
Lai, MY
Lee, PH
Cheng, AL
[J]. ONCOLOGY, 2003, 65 (03) : 242 - 249
[10] Thalidomide: A review of approved and investigational uses
Matthews, SJ
McCoy, C
[J]. CLINICAL THERAPEUTICS, 2003, 25 (02) : 342 - 395

← 1 2 →